49 research outputs found
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
Get PDF
Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study
Full text linkEfficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study
Get PDF
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS
No full textMulticenter feasibility study of 5-FU, leucovorin, plus paclitaxel (FLTAX) for peritoneal disseminated gastric cancer with massive ascites or inadequate oral intake.
No full text
Prognostic factors in Japanese patients with advanced gastric cancer using the data from JCOG9912 study.
No full text
